InflaRx NV
NASDAQ:IFRX

Watchlist Manager
InflaRx NV Logo
InflaRx NV
NASDAQ:IFRX
Watchlist
Price: 2.03 USD 18.71% Market Closed
Market Cap: 119.5m USD
Have any thoughts about
InflaRx NV?
Write Note

InflaRx NV
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

InflaRx NV
Cash & Cash Equivalents Peer Comparison

Comparables:
BNTX
MOR
IMTX
BIO
FYB

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
InflaRx NV
NASDAQ:IFRX
Cash & Cash Equivalents
€6.8m
CAGR 3-Years
-15%
CAGR 5-Years
-34%
CAGR 10-Years
N/A
BioNTech SE
NASDAQ:BNTX
Cash & Cash Equivalents
€11.7B
CAGR 3-Years
113%
CAGR 5-Years
95%
CAGR 10-Years
N/A
MorphoSys AG
XETRA:MOR
Cash & Cash Equivalents
€131.3m
CAGR 3-Years
6%
CAGR 5-Years
22%
CAGR 10-Years
11%
Immatics NV
NASDAQ:IMTX
Cash & Cash Equivalents
€218.5m
CAGR 3-Years
2%
CAGR 5-Years
194%
CAGR 10-Years
N/A
Biotest AG
XETRA:BIO
Cash & Cash Equivalents
€66.3m
CAGR 3-Years
-3%
CAGR 5-Years
6%
CAGR 10-Years
-3%
Formycon AG
XETRA:FYB
Cash & Cash Equivalents
€27m
CAGR 3-Years
-14%
CAGR 5-Years
30%
CAGR 10-Years
N/A

See Also

What is InflaRx NV's Cash & Cash Equivalents?
Cash & Cash Equivalents
6.8m EUR

Based on the financial report for Jun 30, 2024, InflaRx NV's Cash & Cash Equivalents amounts to 6.8m EUR.

What is InflaRx NV's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
-34%

Over the last year, the Cash & Cash Equivalents growth was 22%. The average annual Cash & Cash Equivalents growth rates for InflaRx NV have been -15% over the past three years , -34% over the past five years .

Back to Top